Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Golden Leaf GLH or GLDFf -- Ignore unavailable to you. Want to Upgrade?

To: Berry Picker who wrote (796)	7/26/2016 1:48:00 PM
From: Berry Picker	Respond to of 1211

Golden Leaf excited with positive marijuana studies Golden Leaf Holdings Ltd (C:GLH) Shares Issued 94,540,673 Tuesday July 26 2016 - News Release Mr. Don Robinson reports GOLDEN LEAF HOLDINGS COMMENTS ON RECENT MEDICAL MARIJUANA RESEARCH Golden Leaf Holdings Ltd. has commented on the recent publication of new scientific research that highlights the positive impact of marijuana on health and wellness. As more states in the U.S. lean towards enacting legal medical marijuana programs, a growing body of research appearing in prominent publications is supporting the use of medical marijuana as an alternative to prescription drugs. Don Robinson, Chief Executive Officer of GLH commented, "We are excited about seeing more studies conducted by respected research organizations showing the benefits and lack of side effects for medical marijuana. As opiate addiction and related medical and societal costs continue to increase in the U.S., this research supports using cannabis as an alternative to pharmaceuticals. Growing scientific evidence of benefit may influence pro-marijuana ballot initiatives in November 2016. This aligns with GLH's mission of revolutionizing health and wellness and improving lives with cannabis." The journal Health Affairs recently published research showing that in the 17 states that made medical marijuana legal by 2013, prescriptions for a variety of drugs covered by Medicare declined as compared to states lacking medical marijuana laws. Researchers at the University of Georgia examined data for prescription drugs purchased under Medicare Part D from 2010-2013. They found drops in Medicare prescriptions and spending on painkillers and opiates, including those used to treat depression, anxiety and chronic pain. Based upon this evidence, the researchers concluded that a high probability existed that medical marijuana legalization drove the prescription decline. According to the Health Affairs research, Medicare saved over $165 million in 2013 alone, among the 17 states that had legalized medical marijuana. In a report published in Aging and Mechanisms of Disease, Scientists at the Salk Institute found that marijuana might play a positive role in treating Alzheimer's disease. Cannabis contains compounds that have an anti-inflammatory impact and could help support the prevention of nerve cell damage that hinder people with Alzheimer's. Tetrahydrocannabinol, one of the compounds discovered, can help with the elimination of amyloid beta, a protein linked to Alzheimer's disease. We seek Safe Harbor.